Sequencing Library Preparation Using Unusual Nucleotides

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Next-generation DNA sequencing technologies face challenges in accuracy, particularly in deep sequencing of genetically heterogeneous mixtures like tumors or microbial populations, due to inherent error rates and artefacts from multiplex PCR, such as false negatives and positives from non-specific priming events.

Innovation Solution

A method involving linear amplification using unusual nucleotides that inhibit exponential PCR production while allowing efficient generation of modified complementary strands, utilizing a first polymerase that incorporates these nucleotides but not as templates, followed by amplification with a second polymerase capable of using these strands, to create a sequencing library suitable for massive parallel sequencing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If multiplex PCR is used to amplify large complex fragments, then productivity is improved, but manufacturing precision deteriorates due to artefacts from non-specific priming events

Engineering Contradiction:
Improveamplification throughputVSAvoidamplification accuracy
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent changes the chemical parameter of the reaction by incorporating unusual nucleotides (dUTP, dITP, dPTP, d5SICS) that alter the amplification dynamics. These modified nucleotides enable linear amplification instead of exponential PCR, reducing non-specific priming while maintaining productivity through controlled strand displacement synthesis

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces strand displacement enzymes (RecJ, ExoVII, Bst polymerase) as intermediaries that mediate the amplification process. These enzymes enable controlled linear amplification by displacing previously synthesized strands, preventing the formation of non-specific products while maintaining high throughput

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If standard PCR amplification is used, then productivity is improved, but reliability deteriorates due to false positive and false negative results

Engineering Contradiction:
Improveamplification efficiencyVSAvoidsequencing accuracy
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent segments the amplification process into distinct phases: initial strand displacement synthesis using unusual nucleotides, followed by separate steps for incorporating standard nucleotides and performing targeted amplification. This segmentation allows each phase to be optimized independently, improving both reliability and productivity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent converts the potential harm of non-specific priming into a benefit by using the unusual nucleotide incorporation as a marker to identify and exclude artefactual sequences. The modified nucleotides serve as traceable markers that allow computational filtering of false positives while retaining true signals

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces sequencing errors and artefacts, enhancing the accuracy and reliability of DNA sequencing by distinguishing true mutations from technical errors and minimizing non-specific amplification products.

Implementation Method 1

a first polymerase...incorporating the unusual nucleotide into extension products to produce modified complementary strands

Methodology Applied
Scientific EffectNucleotide incorporation: Enzyme

Data Source

PatentUS20240384261A1Methods, compositions, and kits for preparing sequencing library
Publication Date: 2024.11.21 GENEFIRST
  • US20240384261A1 patent drawing
  • US20240384261A1 patent drawing
  • US20240384261A1 patent drawing

AI summary

This invention relates to methods, compositions and kits for processing a target nucleic acid from one or more samples involving linear amplification and tagging two strands of target sequence. A sequencing library is made from the processed nucleic acids suitable for massive parallel sequencing and comprises a plurality of double-stranded nucleic acid molecules.